• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Creative Bio-Peptides Inc.

Creative Bio-Peptides Inc.

  • Home
  • Company
    • Our Company
    • Our People
  • Science
    • Introduction
    • RECEPTIDES
    • Publications
  • Therapy Areas
    • Persistent Post-Surgical Pain
    • Parkinson’s Disease
    • Opioid Use Disorders
  • News
  • Contact
  • LinkedIn

Latest News

RAP-103 Inhibits Opioid-derived Dependence, Withdrawal and Respiratory Depression 

July 19, 2022

Creative Bio-Peptides, Inc, a preclinical-stage biotechnology company developing novel therapies to balance the innate immune system and promote regeneration of… Continue Reading

RAP-103 Benefits in Pain Published

July 14, 2022

Preclinical Data Demonstrate Potential of Creative Bio-Peptides’ Multi-Chemokine Receptor Antagonist RAP-103 to Provide Opioid Sparing Post-Surgical Pain Relief and Treatment… Continue Reading

BioHealth Innovation Press Release Features Creative Bio-Peptides

November 30, 2021

Read more here Continue Reading

A Conversation with CBO Michael Simon

April 8, 2021

Listen HERE Continue Reading

NIH SBIR AWARD FOR SYNAPSE PROTECTING TREATMENTS FOR ALZHEIMER’S DISEASE

September 28, 2020

Creative Bio-Peptides, Inc has been funded by the National Institute on Aging (NIA) as part of NIH’s strategic plan to… Continue Reading

CREATIVE BIO-PEPTIDES RECEIVES NIH HEAL AWARD FOR OPIOID ABUSE DISORDERS

January 20, 2020

Creative Bio-Peptides, Inc has been funded as part of the NIH’s HEAL Initiative on building technologies to stop the opioid… Continue Reading

CREATIVE BIO-PEPTIDES and LEIDOS AWARDED US DOD CONTRACT

January 18, 2020

RAP-103 is the new oral analog of Peptide T ( Dala1-peptide T-amide, aka"DAPTA") which was discovered as an anti-viral for… Continue Reading

Primary Sidebar

Latest News

  • RAP-103 Inhibits Opioid-derived Dependence, Withdrawal and Respiratory Depression  Jul 19, 2022
  • RAP-103 Benefits in Pain Published Jul 14, 2022
  • BioHealth Innovation Press Release Features Creative Bio-Peptides Nov 30, 2021
  • A Conversation with CBO Michael Simon Apr 8, 2021
  • NIH SBIR AWARD FOR SYNAPSE PROTECTING TREATMENTS FOR ALZHEIMER’S DISEASE Sep 28, 2020
  • CREATIVE BIO-PEPTIDES RECEIVES NIH HEAL AWARD FOR OPIOID ABUSE DISORDERS Jan 20, 2020
  • CREATIVE BIO-PEPTIDES and LEIDOS AWARDED US DOD CONTRACT Jan 18, 2020

Read more news

Footer

Creative Bio-Peptides Inc.

Rockville, MD
USA  20854

  • LinkedIn

  • RAP-103 Inhibits Opioid-derived Dependence, Withdrawal and Respiratory Depression  Jul 19, 2022
  • RAP-103 Benefits in Pain Published Jul 14, 2022
  • BioHealth Innovation Press Release Features Creative Bio-Peptides Nov 30, 2021
  • A Conversation with CBO Michael Simon Apr 8, 2021
  • NIH SBIR AWARD FOR SYNAPSE PROTECTING TREATMENTS FOR ALZHEIMER’S DISEASE Sep 28, 2020
  • CREATIVE BIO-PEPTIDES RECEIVES NIH HEAL AWARD FOR OPIOID ABUSE DISORDERS Jan 20, 2020
  • CREATIVE BIO-PEPTIDES and LEIDOS AWARDED US DOD CONTRACT Jan 18, 2020

Read more news

Copyright © 2023 Creative Bio-Peptides Inc.